These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1479161)

  • 41. Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment.
    Brunner G; Creutzfeldt W; Harke U; Lamberts R
    Digestion; 1988; 39(2):80-90. PubMed ID: 3410170
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group.
    Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir DG; Gillon KR; Peacock RA; Fulton C
    BMJ; 1999 Feb; 318(7182):502-7. PubMed ID: 10024259
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease-a prospective, controlled trial.
    Maton PN; Orlando R; Joelsson B
    Aliment Pharmacol Ther; 1999 Jun; 13(6):819-26. PubMed ID: 10383513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.
    Venables TL; Newland RD; Patel AC; Hole J; Wilcock C; Turbitt ML
    Scand J Gastroenterol; 1997 Oct; 32(10):965-73. PubMed ID: 9361167
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute treatment of reflux oesophagitis: a multicentre study to compare 150 mg ranitidine twice daily with 300 mg ranitidine at bedtime.
    Halvorsen L; Lee FI; Wesdorp IC; Johnson NJ; Mills JG; Wood JR
    Aliment Pharmacol Ther; 1989 Apr; 3(2):171-81. PubMed ID: 2491468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of twice daily doses of 40 or 20 milligrams famotidine or 150 milligrams ranitidine for treatment of patients with moderate to severe erosive esophagitis. Famotidine Erosive Esophagitis Study Group.
    Simon TJ; Berlin RG; Tipping R; Gilde L
    Scand J Gastroenterol; 1993 May; 28(5):375-80. PubMed ID: 8511496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of roxatidine acetate and ranitidine in the treatment of reflux esophagitis. The Roxatidine Esophagitis Study Group.
    Clin Ther; 1993; 15(2):283-93. PubMed ID: 8100189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.
    Klinkenberg-Knol EC; Festen HP; Jansen JB; Lamers CB; Nelis F; Snel P; Lückers A; Dekkers CP; Havu N; Meuwissen SG
    Ann Intern Med; 1994 Aug; 121(3):161-7. PubMed ID: 8017742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [TBL] [Abstract][Full Text] [Related]  

  • 51. U.S. experience with omeprazole in duodenal ulcer. Multicenter double-blind comparative study with ranitidine. The Omeprazole DU Comparative Study Group.
    Valenzuela JE; Berlin RG; Snape WJ; Johnson TL; Hirschowitz BI; Colon-Pagan J; Morse RS; Petrozza J; Van Deventer GM; Cagliola A
    Dig Dis Sci; 1991 Jun; 36(6):761-8. PubMed ID: 2032518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety.
    Dent J; Yeomans ND; Mackinnon M; Reed W; Narielvala FM; Hetzel DJ; Solcia E; Shearman DJ
    Gut; 1994 May; 35(5):590-8. PubMed ID: 8200548
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease.
    Revicki DA; Sorensen S; Maton PN; Orlando RC
    Dig Dis; 1998; 16(5):284-91. PubMed ID: 9892788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. International Pediatric Omeprazole Study Group.
    Hassall E; Israel D; Shepherd R; Radke M; Dalväg A; Sköld B; Junghard O; Lundborg P
    J Pediatr; 2000 Dec; 137(6):800-7. PubMed ID: 11113836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
    Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
    Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A randomized, comparative study of rabeprazole vs. ranitidine maintenance therapies for reflux esophagitis--multicenter study].
    Jee SR; Seol SY; Kim DH; Park SJ; Han SY; Urm SH; Lee JT
    Korean J Gastroenterol; 2005 May; 45(5):321-7. PubMed ID: 15908764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease.
    Jaspersen D; Schwacha H; Schorr W; Brennenstuhl M; Raschka C; Hammar CH
    J Gastroenterol Hepatol; 1996 Oct; 11(10):900-2. PubMed ID: 8912123
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Australian clinical trials of omeprazole in the management of reflux oesophagitis.
    Dent J
    Digestion; 1990; 47 Suppl 1():69-71. PubMed ID: 2093019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis. Results of a German multicenter study.
    Koop H; Schepp W; Dammann HG; Schneider A; Lühmann R; Classen M
    J Clin Gastroenterol; 1995 Apr; 20(3):192-5. PubMed ID: 7797824
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Reflux esophagitis: therapy with H2-blockers, and motility disorders].
    Pace F; Sangaletti O; Zhu H; Bianchi Porro G
    Minerva Chir; 1991 Apr; 46(7 Suppl):163-7. PubMed ID: 2067675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.